TrialThe Journal of allergy and clinical immunology2019

Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.

Jonathan Steinfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.